Molecular Vision 2009; 15:1485-1491 <http://www.molvis.org/molvis/v15/a159>
Received 12 May 2009 | Accepted 28 July 2009 | Published 31 July 2009

This Article

Download PDF

Citation (for Endnote)

Google Scholar

Articles by the Authors

Evaluation of lenticular antioxidant and redox system components in the lenses of acetyl-L-carnitine treatment in BSO-induced glutathione deprivation

R. Elanchezhian,1 M. Sakthivel,1 M. Isai,1 P. Geraldine,1 P.A. Thomas2

1Department of Animal Science, School of Life Sciences, Bharathidasan University, Tiruchirappalli, Tamil Nadu, India; 2Institute of Ophthalmology, Joseph Eye Hospital, Tiruchirappalli, Tamil Nadu, India

Correspondence to: Dr. Pitchairaj Geraldine, Ph.D., Bharathidasan University, Animal Science, School of Life Sciences, Tiruchirrapalli, Tamil Nadu, 620024, India; Phone: +91-431-2407040; FAX: +91-431-2414969; email: gerryarchup@yahoo.co.in

Abstract

Purpose: To investigate whether acetyl-L-carnitine (ALCAR) retards L-buthionine-(S,R)-sulfoximine (BSO)-induced cataractogenesis in Wistar rat pups.

Methods: On postpartum day 3, group I pups received intraperitoneal (ip) saline and group II and group III pups received i.p. injections of BSO once daily for three consecutive days. In addition, group III pups received ip ALCAR once daily from postpartum days 3–15. Both eyes of each pup were examined up from postpartum day 16 to day 30. After sacrifice, extricated pup lenses were analyzed for antioxidant and redox system components.

Results: There was dense lenticular opacification in all group II pups, minimal opacification in 40% of group III pups, and no opacification in 60% of group III pups and in all of group I pups. Group II lenses exhibited significantly lower values of antioxidant and redox system components and higher malondialdehyde concentrations than in group I or group III lenses.

Conclusions: ALCAR prevents cataractogenesis in the BSO-induced cataract model, possibly by inhibiting depleting antioxidant enzyme and redox system components and inhibiting lipid peroxidation.

Introduction

Oxidative stress is a common initiator of many age-related conditions and is probably the most important mechanism in age-related cataractogenesis. Aging of the lens is associated with progressive changes in the physical and chemical properties of its structural proteins, the crystallins. Oxidative stress-induced changes include crystallin cross-linking, aggregation, loss of solubility, conformational alterations, fragmentation, and enzyme inactivation. Highly reactive species such as hydrogen peroxide (H2O2), singlet oxygen, superoxide radicals, and hydroxyl radicals can be generated in the eye through photochemical pathways [1] or Fenton-type reactions [2]. The lens possesses several protective mechanisms to prevent or limit oxidative damage. Normal young lenses maintain optimal activity of antioxidant enzymes and high concentrations of ascorbate and glutathione and hence minimize the alterations wrought by excessive oxidation. If this balance of pro- and antioxidants is disturbed, aging occurs. Under the pathological condition, the oxidation of lenticular proteins may lead to senile cataract [3].

Glutathione is a major constituent of mammalian lenses and is mainly concentrated in the epithelium. Glutathione decreases during the formation of most cataracts [4]. Reduced glutathione (GSH) is present in a high concentration in the lens [5,6]. GSH serves as an intracellularly-produced antioxidant, which resists oxidative damage to cellular organelles by recycling other antioxidants, scavenging free radicals, and using H2O2 and hydroperoxides where it undergoes oxidation by glutathione peroxidase [7,8]. It also promotes the antioxidant properties of vitamin C and vitamin E by maintaining these nutrients in a reduced state [9]. The second line of defense for the health of the lens is its content of intrinsic repair enzymes that constantly dethiolate protein-thiol mixed disulfides (protein thiolation) or protein–protein disulfides, which have been induced by oxidative stress. This process allows lenticular proteins to maintain their free thiols again, thus restoring lenticular proteins as well as the function and activities of enzymes [10]. The role of GSH as an endogenous lenticular antioxidant results in the reduction of lenticular hydrogen peroxide [11] and dehydroascorbate [12].

L-buthionine-(S,R)-sulfoximine (BSO), an inhibitor of GSH biosynthesis, can induce age-dependent cataracts in pre-weaning mice [13] and in early postnatal rats [14] and is thus a potential model for obtaining new information about the role of GSH in maintaining transparency of the lens. In the presence of reduced levels of GSH, newborn rats suffer extensive damage to the cytosolic proteins and membrane lipids, leading to clouding of the lens [15-17]. BSO-induced cataracts have been prevented or reduced in frequency in vivo by esters of GSH [12,14] and by lipoic acid [18] and ascorbate [12].

Acetyl-L-carnitine (ALCAR), a quaternary amine, is a naturally-occurring, short-chain derivative of L-carnitine, which is synthesized endogenously in the human brain, liver, and kidneys by the acetyl carnitine transferase enzyme or obtained from dietary sources [19]. ALCAR facilitates the uptake of acetyl-CoA into the mitochondria during fatty acid oxidation, enhances acetylcholine production, and stimulates synthesis of protein and membrane phospholipids. It also counteracts oxidative stress by inhibiting increases in lipid hydroperoxidation [20]. ALCAR has been reported to prevent selenite-induced cataractogenesis in a Wistar rat model both in vitro and in vivo by maintaining lenticular antioxidant and redox system components [21,22] and lenticular calpain activity [23] at near normal levels. In this study, an attempt has been made to determine the putative anticataractogenic effect of ALCAR by preventing the depletion of glutathione in the BSO-induced cataract model. Certain key biochemical parameters of antioxidant and redox system components and of lipid peroxidation have also been evaluated.

Methods

Experimental animal

Two-day-old rat pups (Wistar strain) were used in this study. The pups were housed with parents in large spacious cages, and the parents were given food and water ad libitum. The animal room was well ventilated, and a regular 12 h light and 12 h dark cycle was maintained throughout the experimental period. These animals were used in accordance with institutional guidelines and with the Association for Research in Vision and Ophthalmology Statement for the Use of Animals in Research. The rat pups were divided into three groups, each group comprising pups from the same litter: Group I, which received only saline (control); Group II, which received BSO (cataract-untreated); Group III, which received BSO and ALCAR (cataract-treated).

Each rat pup in groups II and III received an intraperitoneal (ip) injection of BSO once daily for three consecutive days starting from postpartum day 2. In addition, pups in group III received ip injections of ALCAR (200 mg/kg bodyweight), which was administered half an hour before the BSO injection once a day until the pups opened their eyes.

Morphological examination

When the rat pups first opened their eyes, a slit-lamp biomicroscopic examination was performed on each eye to detect opacification. Prior to performing the examination, mydriasis was achieved by a topical ophthalmic solution, which was instilled every 30 min for 2 h with the animals being kept in a dark room. After 2 h, the eyes were viewed by a slit-lamp biomicroscope (Carl Zeiss, Jena, Germany) at 12X magnification. At the end of the experimental period (postpartum day 30), each eye was photographed, and the degree of opacification was graded as follows: 0=normal transparent lens; +=initial sign of nuclear opacity involving tiny scatters; ++=partial nuclear opacity; and +++=dense nuclear opacity.

Biochemical evaluation of redox system components and antioxidant enzymes

Rat pups in all three groups were anesthetized and then sacrificed by cervical dislocation on postpartum day 30. The lenses were then excised. Both lenses of each individual rat were processed together to constitute a single value. The lenses were homogenized in 50 mM phosphate buffer (pH 7.2; 1 ml/ 100 mg tissue) and centrifuged at 14,006x g for 15 min at 4 °C. The supernatant obtained was used for the analysis of enzymatic and non-enzymatic parameters. To calculate the specific enzyme activity, protein in each sample was estimated by the method of Bradford [24].

Reduced glutathione

The GSH content was estimated by the method of Moron et al. [25]. The lens homogenate was centrifuged at 2,432x g for 15 min at 4 °C. To the resulting supernatant, 0.5 ml of 10% trichloroacetic acid was added, and the mix was recentrifuged. The resulting protein-free supernatant was allowed to react with 4 ml of 0.3 M Na2HPO4 (pH 8.0) and 0.5 ml of 0.04% (wt/vol) 5,5-dithiobis-2-nitrobenzoic acid. The absorbance of the resulting yellow color was read spectrophotometrically at 412 nm. A parallel standard was also maintained. The results were expressed in μmoles/g wet weight.

Glutathione reductase

This enzyme, which utilizes nicotinamide adenine dinucleotide phosphate (NADPH) to convert oxidized glutathione to the reduced form, was assayed by the method of Stall et al. [26]. The change in absorbance was read at 340 nm for 2 min at intervals of 30 s in an ultraviolet (UV) spectrophotometer (Analytik Jena AG, Jena, Germany). The activity of glutathione reductase (GR) was expressed as nmoles of NADPH oxidized/min/mg protein.

Glutathione S-transferase

The activity of glutathione S-transferase (GST) was determined by the method of Habig and Jacoby [27]. The conjugation of GSH with 1-chloro-2,4-dinitrobenzene (CDNB), a hydrophilic substrate, was observed spectrophotometrically at 340 nm to measure the activity of GST. One unit of GST was defined as the amount of enzyme required to conjugate 1 μmol of CDNB with GSH per min.

Glutathione peroxidase

The activity of glutathione peroxidase (GPx) was determined essentially as described by Rotruck et al. [28]. The principle of this method is that the rate of glutathione oxidation by H2O2 as catalyzed by the GPx present in the supernatant is determined. The color that develops is read against a reagent blank at 412 nm on a spectrophotometer. In the test, the enzyme activity was expressed as units/mg protein (one unit was the amount of enzyme that converted 1 µmole of GSH to the oxidized form of glutathione [GSSH] in the presence of H2O2 per min).

Catalase

Catalase (CAT) activity was determined by the method of Sinha [29]. In this test, dichromatic acetic acid is reduced to chromic acetate when heated in the presence of H2O2 with the formation of perchloric acid as an unstable intermediate. In the test, the green color developed was read at 590 nm against a blank on a spectrophotometer. The activity of catalase was expressed as units/mg protein (one unit was the amount of enzyme that used 1 mmole of H2O2 per min).

Superoxide dismutase

Superoxide dismutase (SOD) activity was determined by the method of Marklund and Marklund [30]. In this test, the degree of inhibition of pyrogallol auto-oxidation by the supernatant of the lens homogenate was measured. The change in absorbance was read at 470 nm against the blank each min for 3 min on a spectrophotometer. The enzyme activity was expressed as units per mg protein.

Determination of lipid peroxidation

The extent of lipid peroxidation was determined by the method of Ohkawa et al. [31]. The principle of this method is that malondialdehyde (MDA), an end-product of lipid peroxidation, reacts with thiobarbituric acid (TBA) to form a pink chromogen. For this assay, 0.2 ml of 8.1% sodium dodecyl sulfate, 1.5 ml of 20% acetic acid (pH 3.5), and 1.5 ml of 0.81% thiobarbituric acid aqueous solution were added in succession in a reaction tube. To this reaction mixture, 0.2 ml of the lens homogenate was added, and the mixture was then heated in boiling water for 60 min. After cooling to room temperature, 5 ml of the butanol:pyridine (15:1 v/v) solution were added. The mixture was then centrifuged at 2,432x g for 15 min and the upper organic layer was separated. The intensity of the resulting pink color was then read at 532 nm, and the result was expressed as nmoles of MDA formed per gram wet weight.

Statistical analysis

The mean value of each parameter in each individual group of rats was calculated from at least five individual values and was expressed as mean±SD. Statistical analysis was done by using the Student’s t-test and χ2 test where appropriate, and p values less than 0.05 were considered statistically significant.

Results

Morphological examination

Slit-lamp examination revealed that all 15 rat pups in group II (Figure 1 and Table 1) exhibited dense opacification of the lens (grade +++). In contrast, only 6 of 15 (40%) rat pups in group III (Figure 2 and Table 1) exhibited lenticular opacification (grade +) with the lenses of the other nine pups appearing normal (grade 0). All 15 rat pups in group I exhibited maximum transparency (grade 0) of the lens (Figure 3 and Table 1). The difference between the value in group II and group III rats was statistically significant (χ2 [degrees of freedom=1]=12.8; p<0.01).

Biochemical evaluation of lenticular antioxidant and redox system components

Redox system components-- The mean activities of GR, GST, and GPx and the mean level of GSH in lenses of BSO-injected rats (group II) were significantly lower than those in lenses of normal rats (group I) (p<0.05; Table 2). The mean activities of GR, GST, and GPx and the mean level of GSH were significantly higher in lenses of group III rats than those in lenses of group II rats (p<0.05). However, no significant differences were observed in the mean activities of GR, GST, and GPx and the mean level of GSH between lenses of normal rats (group I) and the lenses of ALCAR-treated rat lenses (group III; Table 2).

Antioxidant enzymes-- The mean activities of CAT and SOD in lenses of BSO-injected rats (group II) were significantly lower than the values in lenses of normal rats (group I) that had received saline alone (p<0.05; Table 3). Treatment with ALCAR appeared to exert a beneficial effect since the activities of CAT and SOD were significantly (p<0.05) higher in lenses of group III rats than group II rats (Table 3).

Determination of lipid peroxidation-- The mean MDA level was found to be significantly higher in lenses of BSO-injected rats (group II) than in normal rats (group I; p<0.05; Figure 4). However, the mean MDA level in group III rat lenses (treated with ALCAR) was significantly lower than in group II rat lenses (p<0.05), presumably due to limitation of lipid peroxidation.

Discussion

Cataract formation is associated with oxidative insults such as loss of lenticular glutathione, excessive H2O2, accumulation of lipid peroxides, and lack of oxygen-detoxifying enzymes [32-34]. Humans exposed to hyperbaric oxygen have been found to develop cataract [35]. The role of such oxidative insults in cataractogenesis led us to investigate the role of ALCAR, a known antioxidant, in the prevention of lenticular opacification in newborn rats exposed to BSO. Gross morphological examination appeared to suggest that ALCAR is able to significantly retard BSO-induced cataractogenesis since 100% of rats receiving BSO alone developed dense lenticular opacification while 60% of rats receiving BSO and ALCAR did not develop any lenticular opacification (Figure 1, Figure 3; Table 1).

A high concentration of GSH, a major intracellular antioxidant, has been found to protect the lens from oxidative damage due to toxic chemicals [36]. Thus, depletion of GSH seriously affects GSH-dependent enzymes such as GPx, GR, and GST as well as leukotriene C4 synthetase and the glutaredoxin system, which renders the cells to be susceptible to a toxic challenge [37]. GR maintains the intracellular level of GSH by preserving the integrity of cell membranes and by stabilizing the sulfhydryl groups of proteins. Administration of carnitine and lipoic acid to aged rats has been found to increase the activity of GR by increasing the levels of GSH and the reducing equivalent of NADPH [38,39].

Depletion of GSH appears to be the prime cause of BSO-induced cataract [13]. In the present study, the levels of redox system components (GSH, GR, and GST) were found to be significantly lower in lenses of BSO-administered rats than in normal rat lenses (Table 3). These lowered activities were possibly due to the depletion of the lenticular GSH pool that occurred as a consequence of exposure to BSO. Similar observations have already been reported [40,41]. In the lenses of group III rats (exposed to BSO and treated with ALCAR), the mean level of GSH and the mean activities of GR and GST were found to be significantly higher than the values in the lenses of rats that were administered BSO alone (Table 3). Similar observations have been reported in the selenite-induced cataract model [22]. In fact, the GSH/GPx system has been known to function as an antioxidant system in the mitochondria and cytoplasm of lens epithelial cells. The depletion of lenticular GSH in animals receiving BSO alone and the increased level of GSH following administration of ALCAR may be due to improved energy metabolism, inhibition of electron leakage from mitochondrial electron transport systems [42], and enhanced repair of oxidized membrane/lipid bilayers [43,44], thereby maintaining lenticular GSH levels.

CAT, SOD, and GPx are important components of the innate antioxidant enzymatic defenses of the lens. CAT is able to detoxify significant amounts of H2O2 [45]. SOD catalyzes the removal of superoxide radicals (O2-), which would otherwise damage the membrane and other biological structures [46]. The enzyme, GPx, first demonstrated in the lens by Pirie [47], has been reported to maintain the integrity of the phospholipid bilayer of membranes by inhibiting lipid peroxidation. Thus, CAT and GPx catalyze the transformation of H2O2 within the cell to harmless by-products, thereby curtailing the quantity of cellular destruction inflicted by products of lipid peroxidation. A reduction in the activities of these enzymes in tissues has been associated with the accumulation of highly reactive free radicals, leading to loss of the integrity and function of cell membranes [45,48,49]. In the present in vivo study, the mean activities of CAT, SOD, and GPx were found to be significantly lower in the lenses of rats exposed to BSO alone than those in normal rat lenses (Table 2). Such a reduction in the activities of these enzymes in BSO-induced cataractogenesis has been reported in vitro [50] and in vivo [18,51]. However, in the lenses of rats that had been exposed to BSO and treated with ALCAR, the activities of these enzymes were maintained at near normal levels.

The excessive generation of free radicals leads to peroxidative changes that ultimately result in enhanced lipid peroxidation [52], which causes changes in biochemical processes and structural integrity and leads to cellular damage [53]. In the present investigation, the mean level of lenticular MDA was found to be significantly higher in rats that had been administered BSO alone than in normal rats. However, the mean levels of MDA were significantly lower in lenses of group III rats (BSO-administered and ALCAR-treated) than in group II rat lenses (Figure 4). Thus, lenses of rats given BSO alone showed a significant depletion of GSH and increased membrane damage as indicated by the increased levels of MDA (Figure 4). However, ALCAR appeared to prevent the occurrence of such changes. Similar protective effects of ALCAR have been previously reported in selenite-challenged rat lenses [22].

We have previously reported that ALCAR appears to prevent selenite-induced cataractogenesis [22]. The results of the present study add support to our hypothesis that ALCAR can also prevent cataractogenesis that is mediated by glutathione deprivation and induced by BSO. These preventive effects of ALCAR are suggested by its ability to maintain lenticular antioxidant and redox system components at near normal levels and to prevent excessive lipid peroxidation. The relevance of these results in the context of human senile cataractogenesis requires further study.

Acknowledgments

The authors thank the Department of Biotechnology (DBT), Government of India, for the financial assistance provided. Instrumentation facility provided by DST-FIST and UGC-SAP of the Department of Animal Science at Bharathidasan University (Tiruchirappalli, India) is also acknowledged.

References

  1. Linetsky M, James HL, Ortwerth BJ. Spontaneous generation of superoxide anion by human lens proteins and by calf lens proteins ascorbylated in vitro. Exp Eye Res. 1999; 69:239-48. [PMID: 10433859]
  2. Fu S, Dean R, Southan M, Truscott R. The hydroxyl radical in lens nuclear cataractogenesis. J Biol Chem. 1998; 273:28603-9. [PMID: 9786852]
  3. Spector A. Oxidative stress-induced cataract: mechanism of action. FASEB J. 1995; 9:1173-82. [PMID: 7672510]
  4. Laver NM, Robison WG, , Jr Calvin HI, Fu SCJ. Early epithelial lesions in cataracts of GSH depleted mouse pups. Exp Eye Res. 1993; 57:493-8. [PMID: 8282035]
  5. Reddy VN. Metabolism of glutathione in the lens. Exp Eye Res. 1971; 11:310-28. [PMID: 4399363]
  6. Hata N, Hockwin O. Enzymatic determination of reduced and oxidized glutathione in bovine lenses if different ages and their distribution in lens equator and nucleus. Ophthalmic Res. 1977; 9:256
  7. Meister A. On the antioxidant effects of ascorbic acid and glutathione. Biochem Pharmacol. 1992; 44:1905-15. [PMID: 1449510]
  8. Anderson ME. Glutathione and glutathione delivery compounds. Adv Pharmacol. 1997; 38:65-78. [PMID: 8895804]
  9. May JM, Qu ZC, Whitesell RR, Cobb CE. Ascorbate recycling in human erythrocytes: role of GSH in reducing dehydroascorbate. Free Radic Biol Med. 1996; 20:543-51. [PMID: 8904295]
  10. Lou MF. Thiol regulation in the lens. J Ocul Pharmacol Ther. 2000; 16:137-48. [PMID: 10803424]
  11. Giblin FJ, Reddan JR, Schrimscher L, Dziedzic DC, Reddy VN. The relative roles of the glutathione redox cycle and catalase in the detoxification of H2O2 by cultured rabbit lens epithelial cells. Exp Eye Res. 1990; 50:795-804. [PMID: 2373171]
  12. Martensson J, Meister A. Glutathione deficiency decreases tissue ascorbate levels in newborn rats: Ascorbate spares glutathione and protects. Proc Natl Acad Sci USA. 1991; 88:4656-60. [PMID: 2052548]
  13. Calvin HI, Medvedovsky C, Worgul BV. Near-total glutathione depletion and age-specific cataracts induced by buthionine sulfoximine in mice. Science. 1986; 233:553-5. [PMID: 3726547]
  14. Martensson J, Steinherz R, Jain A, Meister A. Glutathione ester prevents buthionine sulfoximine-induced cataracts and lens epithelial cell damage. Proc Natl Acad Sci USA. 1989; 86:8727-31. [PMID: 2813421]
  15. Spector A. The lens and oxidative stress. In: Seis H, editor. Oxidative stress: oxidants and antioxidants. London: Academic Press 1991; pp 529–58.
  16. Jacques PF, Chylacjrk LT, Taylor A. Relationship between natural antioxidants and cataract formation. In: Frei B, editor. Natural antioxidants in human health and disease. San Diego: Academic Press; 1994. p. 515–33.
  17. Taylor A, Nowel T. Oxidative stress and antioxidant function in relation to the risk for cataract. Adv Pharmacol. 1997; 38:515-36. [PMID: 8895822]
  18. Maitra I, Serbinova E, Trischler H, Packer L. Alpha-lipoic acid prevents buthionine sulfoximineinduced cataract formation in newborn rats. Free Radic Biol Med. 1995; 18:823-9. [PMID: 7750805]
  19. Goa KL, Brogden RN. L–Carnitine. A preliminary review of its pharmacokinetics, and its therapeutic use in ischaemic cardiac disease and primary and secondary carnitine deficiencies in relationship to its role in fatty acid metabolism. Drugs. 1987; 34:1-24. [PMID: 3308409]
  20. Yasui F, Matsugo S, Ishibashi M, Kajita T, Ezashi Y, Oomura Y. Effects of chronic acetyl-L-carnitine treatment on brain lipid hydroperoxide level and passive avoidance learning in senescence-accelerated mice. Neurosci Lett. 2002; 334:177-80. [PMID: 12453624]
  21. Geraldine P, Sneha BB, Elanchezhian R, Ramesh E, Kalavathy CM, Kaliamurthy J, Thomas PA. Prevention of selenite-induced cataractogenesis by acetyl-L-carnitine: an experimental study. Exp Eye Res. 2006; 83:1340-9. [PMID: 16962580]
  22. Elanchezhian R, Ramesh E, Sakthivel M, Isai M, Geraldine P, Rajamohan M, Nelson Jesudasan C, Thomas PA. Acetyl-L-Carnitine prevents selenite-induced cataractogenesis in an experimental animal model. Curr Eye Res. 2007; 32:961-71. [PMID: 18027172]
  23. Elanchezhian R, Sakthivel M, Geraldine P, Thomas PA. The effect of acetyl-l-carnitine on lenticular calpain activity in prevention of selenite-induced cataractogenesis. Exp Eye Res. 2009; 88:938-44. [PMID: 19150348]
  24. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976; 72:248-54. [PMID: 942051]
  25. Moron MS, Depierre JW, Mannervik B. Levels of glutathione, glutathione reductase and glutathione-S-transferase activities in rat lung and liver. Biochim Biophys Acta. 1979; 582:67-78. [PMID: 760819]
  26. Staal GE, Visser J, Veeger C. Purification and properties of glutathione reductase of human erythrocytes. Biochim Biophys Acta. 1969; 185:39-48. [PMID: 5796111]
  27. Habig WH, Jacoby WB. Assays for differentiation of glutathione-Stransferase. Methods Enzymol. 1981; 77:398-405. [PMID: 7329316]
  28. Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hoekstra WG. Selenium: biochemical role as a component of glutathione peroxidase. Science. 1973; 179:588-90. [PMID: 4686466]
  29. Sinha AK. Colorimetric assay of catalase. Anal Biochem. 1972; 47:389-94. [PMID: 4556490]
  30. Marklund S, Marklund G. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem. 1974; 47:469-74. [PMID: 4215654]
  31. Ohkawa H, Ohishi N, Yagi K. Assay of lipid peroxide in animal tissue by thiobarbituric acid reaction. Anal Biochem. 1979; 95:351-8. [PMID: 36810]
  32. Bhuyan KC, Bhuyan DK. Molecular mechanisms of cataractogenesis: III. Toxic metabolites of oxygen as initiators of lipid peroxidation and cataract. Curr Eye Res. 1984; 3:67-81. [PMID: 6317286]
  33. Meister A. Glutathione deficiency produced by inhibition of its synthesis, and its reversal; applications in research and therapy. Pharmacol Ther. 1991; 51:155-94. [PMID: 1784629]
  34. Mitton KP, Dean PA, Dzialoszynski T, Xiong H, Sanford SE, Trevithick JR. Modelling cortical cataractogenesis: 13. Early effects on lens ATP/ADP and glutathione in the streptozotocin rat model of the diabetic cataract. Exp Eye Res. 1993; 56:187-98. [PMID: 8462652]
  35. Palmquist BM, Philipson B, Barr PO. Nuclear cataract and myopia during hyperbaric oxygen therapy. Br J Ophthalmol. 1984; 68:113-7. [PMID: 6691953]
  36. Hightower KR, McCready JP. Effect of selenite on epithelium of cultured rabbit lens. Invest Ophthalmol Vis Sci. 1991; 32:406-9. [PMID: 1825204]
  37. Kumaran S, Savitha S, Anusuya Devi M, Panneerselvam C. Lcarnitine and DL-alpha-lipoic acid reverse the age-related deficit in glutathione redox state in skeletal muscle and heart tissues. Mech Ageing Dev. 2004; 125:507-12. [PMID: 15246746]
  38. Arivazhagan P, Ramanathan K, Panneerselvam C. Effect of DL-alphalipoic acid on glutathione metabolic enzymes in aged rats. Exp Gerontol. 2001; 37:81-7. [PMID: 11738149]
  39. Rani PJ, Panneerselvam C. Effect of L-carnitine on brain lipid peroxidation and antioxidant enzymes of old rats. J Gerontol A Biol Sci Med Sci. 2002; 57:B134-7. [PMID: 11909877]
  40. Bhuyan KC, Bhuyan DK, Podos SM. Cataract induced by selenium in rats. II. Increased lipid peroxidation and impairment of enzymatic defenses against oxidative damage. IRCS Med Sci. 1981; 9:195-6.
  41. Huang LL, Zhang CY, Hess JL, Bunce GE. Biochemical changes and cataract formation in lenses from rats receiving multiple, low doses of sodium selenite. Exp Eye Res. 1992; 55:671-8. [PMID: 1478277]
  42. Trush MA, Kensler TW. An overview of the relationship between oxidative stress and chemical carcinogenesis. Free Radic Biol Med. 1991; 10:201-9. [PMID: 1864525]
  43. Arduini A. Carnitine and its acyl esters as secondary antioxidants? Am Heart J. 1992; 123:1726-7. [PMID: 1595568]
  44. Liu J, Head E, Gharib AM, Yuan W, Ingersoll RT, Hagen TM, Cotman CW, Ames BN. Memory loss in old rats is associated with brain mitochondrial decay and RNA/DNA oxidation: partial reversal by feeding acetyl-L-carnitine and/or R-alpha -lipoic acid. Proc Natl Acad Sci USA. 2002; 99:2356-61. [PMID: 11854529]
  45. Cheng L, Kellogg EW, , 3rd Packer L. Photoinactivation of catalase. Photochem Photobiol. 1981; 34:125-9. [PMID: 7291325]
  46. Krishnakantha TP, Lokesh BR. Scavenging of superoxide anions by spice principles. Indian J Biochem Biophys. 1993; 30:133-4. [PMID: 8394839]
  47. Pirie A. Glutathione peroxidase in lens and a source of hydrogen peroxide in aqueous humour. Biochem J. 1965; 96:244-53. [PMID: 14343138]
  48. Reddy AC, Lokesh BR. Studies on spice principle as an antioxidant in the inhibition of lipid peroxidation of rat liver microsomes. Mol Cell Biochem. 1992; 111:117-24. [PMID: 1588934]
  49. Sheela CG, Angusti K. Antiperoxide effects of S-allyl cystein sulphoxide isolated from Allium sativum Linn and gugulipid in chlosterol diet fed rats. Indian J Exp Biol. 1995; 33:337-41. [PMID: 7558192]
  50. Calvin HI, Banerjee U, Fu SC. Inhibition of mouse BSO cataracts by the protein-kinase inhibitor, H-7. Invest Ophthalmol Vis Sci. 1997; 38:5376
  51. Li ZR, Reiter RJ, Fujimori O, Oh CS, Duan YP. Cataractogenesis and lipid peroxidation in newborn rats treated with buthionine sulfoximine: Preventive actions of melatonin. J Pineal Res. 1997; 22:117-23. [PMID: 9213264]
  52. Rikans LE, Hornbrook KR. Lipid peroxidation, antioxidant protection and aging. Biochim Biophys Acta. 1997; 1362:116-27. [PMID: 9540842]
  53. Bhatia AL, Jain M. Spinacia oleracea L. protects against gamma radiations: a study on glutathione and lipid peroxidation in mouse liver. Phytomedicine. 2004; 11:607-15. [PMID: 15636174]